watch cnbc's full interview with novartis ceo vas narasimhan
Published 4 years ago • 4.6K plays • Length 7:51Download video MP4
Download video MP3
Similar videos
-
3:43
novartis ceo vas narasimhan on the latest research on a breast cancer drug
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
6:12
novartis ceo: expect continued growth in 2023
-
3:42
novartis ceo vasant narasimhan on building trust with society
-
3:01
novartis ceo vas narasimhan: strategic approach to weight-loss drug development | n18v | cnbc tv18
-
3:45
neuberger berman's dan flax on buying the tech sector dip
-
5:20
'attractive' growth ahead for novo nordisk, ceo says
-
1:14:03
south asian trailblazers: vas narasimhan (ceo of novartis) and srishti gupta (leader in health & ed)
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
4:22
novartis ceo on new cancer therapy programs
-
12:38
health care in a post-pandemic world with vas narasimhan novartis at cnbc evolve global summit 2021
-
26:06
looking for a better owner for our india-listed biz: novartis ceo | exclusive | global dialogues
-
3:47
novartis ceo: demand has surged for therapeutics
-
14:57
median pay at novartis is higher for women than men: novartis ceo vas narasimhan | cnbc tv18
-
6:15
coronavirus: novartis ceo vas narasimhan on the timeline for coronavirus treatments
-
4:16
novartis ceo vas narasimhan: our medicines are starting to take market share and deliver on promises
-
6:28
novartis ceo discusses developing a new covid-19 treatment
-
1:51
committed to growing over 4% through 2026, says novartis ceo
-
0:57
novartis global ceo vas narasimhan: ai's impact on pharma and clinical trial realities | n18s
-
7:41
novartis ceo on company's approach to covid-19 treatment
-
2:05
ceo of swiss drugmaker novartis outlines some major industry trends for 2024
-
2:18
novartis ceo: we're moving toward filing covid drug from molecular partners with fda